








Confocal endomicroscopy identifies loss of local barrier function in the duodenum of patients with Crohn’s disease and ulcerative colitis
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Background: Increased cell shedding with gap formation and local barrier dysfunction can be identified endomicroscopically in the terminal ileum of patients with IBD. We aim to evaluate whether these changes are also present in the duodenum of patients with IBD.
Methods: 15 patients with Crohn’s disease (CD), 10 patients with Ulcerative Colitis (UC) and 10 controls underwent fluorescein-aided confocal laser endomicroscopy (CLE). CLE was performed on macroscopically normal antral and duodenal (D1,D2,D3,D4) mucosa. Representative CLE images were prospectively analyzed. Images were scored for the number of epithelial gaps, cell shedding and the degree of fluorescein leakage into the intestinal lumen. 
Results: Both CD and UC patients had significantly more epithelial gaps, epithelial cell shedding, and leakage of fluorescein into the duodenal lumen than controls. The degree of cell shedding and epithelial gap formation was similar in CD and UC patients. In all cases macroscopic endoscopic appearances of the duodenum were normal and conventional histological analysis showed a mild non-specific duodenitis in 7/15 CD patients. UC patients had a histologically normal duodenum. Gap formation, cell shedding and fluorescein leakage was similar in CD with active compared to inactive disease, except for D2 shedding.
Conclusions: CLE can detect epithelial damage and barrier loss in the duodenum of CD and UC patients that is not apparent on conventional endoscopy or histology. 




The intestinal epithelium forms a barrier between the body and contents of gut. Barrier loss allowing entry of antigens, toxins and micro-organisms has been implicated in the pathogenesis of inflammatory bowel disease.[] Normal intestinal epithelial cells migrate upwards from the base of the crypt to the villus, or crypt mouth in the colon, from where they are shed.[] Although physiological cell shedding results in transient discontinuities in the epithelial layer termed gaps, epithelial barrier function remains intact as a result of redistribution of tight junction proteins around the shedding cell. ADDIN EN.CITE [] During inflammation epithelial cell shedding is increased and in a proportion of cases the mechanisms for maintaining barrier function at sites of cell shedding start to fail. ADDIN EN.CITE [,]

Confocal laser endomicroscopy (CLE) is an endoscopic technique which allows the in vivo examination of living cells and vasculature of the mucosal layer of the gastrointestinal tract during ongoing endoscopy. Endomicroscopy provides sub-cellular resolution with magnification up to 1000-fold, enabling the identification of epithelial cell shedding and identification of local barrier dysfunction. We have recently shown that cell shedding and loss of epithelial barrier function at sites of cell shedding can be detected in humans by confocal laser endomicroscopy.[] A grading system for evaluating the severity of epithelial cell loss and loss of barrier function has been devised. Using this system we have shown that cell shedding, microerosion formation and barrier loss is increased in the terminal ileum of patients with Crohn’s disease or Ulcerative colitis compared to controls. We have also shown that by performing CLE in IBD patients in remission and classifying them according to the Watson grading system it is possible to predict relapse over the following 12 months.[]  These studies show that by imaging of the intestine with CLE it is possible to make functional measurements that have relevance to the pathogenic mechanisms of both Crohn’s disease and Ulcerative colitis and its prognosis. 

The duodenum is not a common site of inflammation in Crohn’s disease and is classically not involved in ulcerative colitis which by definition is restricted to the colon. Our studies of cell shedding suggest that increased cell shedding and barrier loss may be an underlying pathomechanism of IBD and also may be sensitive indicators of inflammatory activity. 








This prospective study recruited patients from a university hospital endoscopy unit. Patients with IBD were eligible for inclusion if they had known histological diagnosis of CD or UC, and presented to the endoscopy unit for colonoscopy because of surveillance or gastrointestinal symptoms. Patients were offered additional esophagogastroduodenoscopy and confocal laser endomicroscopy for study purposes. Controls were eligible for inclusion if they had no known or suspected history of IBD, and presented to the endoscopy unit for esophago​gastroduodenoscopy for indications other than IBD. Exclusion criteria for all subjects included: inability to give informed consent; acute gastrointestinal bleeding; coagulopathy, impaired renal function (creatinine level >1.2 mg/dL), pregnancy or lactation; known allergy to fluorescein; known diagnosis of CD involving the upper small bowel (duodenum/jejunum); clinical suspicion or known diagnosis of fulminant colitis, abdominal abscess or perforation; and need for immediate surgery. Informed consent was obtained from the subjects who were recruited for this study. None of the patients or controls was taking aspirin or NSAIDs. The study was approved by the local ethical committee in Rheinland-Pfalz, Germany (No 2010/8-147).

Patient characteristics
Data including age, gender, duration of disease, medication, indication for endoscopy, laboratory investigations and activity index were collected (Table 1). Crohn’s disease activity index (CDAI) and  simple clinical colitis activity index (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​9771402​) (SCCAI) was used to assess the activity in CD and UC, respectively.[]

Endoscopic Procedures
All recruited subjects underwent esophagogastroduodenoscopy with a confocal laser endomicroscope. This comprises conventional video endoscope into which a miniaturized confocal microscope has been incorporated into its distal tip (EC 3830FK; Pentax, Tokyo, Japan). This instrument can undertake standard video endoscopy together with confocal endomicroscopy of the mucosal layer, providing a field of view of 475 by 475 microns of gray-scale images, the optical slice thickness of each image being 7 microns with a lateral resolution of 0.7 microns. For CD and UC patients but not controls, esophagogastroduodenoscopy was followed by colonoscopy with ileal intubation. 
All subjects were given propofol (DISOPRIVAN®, AstraZeneca, Wilmington, Delaware, USA) sedation for the endoscopy. The subjects received monitoring of blood pressure, pulse rate and oxygen saturation during the procedure. Supplemental oxygen was given in all cases. White-light endoscopy was performed first, and any macroscopic abnormalities were noted. Just prior to endomicroscopy, 5ml (10%) of fluorescein sodium (Sciencelab.com, Inc., Houston, Texas, USA) was injected intravenously. The white-light and confocal endomicroscopic examination was performed up to second part of the duodenum (D2) for the first 8 subjects (5 CD patients, 2 UC patients and 1 control), with endomicroscopic examination starting from D2, followed  by duodenal bulb (D1), followed by gastric antrum. For all subsequent patients, endomicroscopy was performed first in the most distal part of the duodenum accessible by endoscopy (D4), followed by the third part of the duodenum (D3), followed by D2, followed by D1, and finally the gastric antrum. The reason for this change was the observation of an apparent increase in epithelial gaps from antrum to D1 to D2 in IBD among these first 8 subjects. For each site, endomicroscopic images were obtained from macroscopically normal looking mucosa, from at least three different fields of view. At least 3 images were obtained per z-stack, including surface epithelium. When macroscopic mucosal erythema was present, confocal endomicroscopy was performed at least 2 cm away from the erythema. Tissue biopsies were obtained from the duodenal bulb and antrum.
After the esophagogastroduodenoscopy was completed, all CD and UC patients received colonoscopy with terminal ileal intubation whenever possible. Upon intubation of the terminal ileum, after examination with white-light endoscopy, confocal images were obtained only if the fluorescein signal was still optimal. Terminal ileal biopsies were obtained. The endoscope was then withdrawn, and any macroscopic colonic mucosal abnormality was noted. Tissue biopsies of the colon were obtained as per clinical indication. 

Analysis of confocal endomicroscopic images
Analysis of the stored confocal endomicroscopic images was done with the image-processing software, Image-J (National Institutes of Health, USA), on gray-scale images with a resolution of 1024 by 1024 pixels. Three representative good-quality images from each site were selected for the objective analysis. For each site, all analysed parameters were expressed as the mean values of the three images.
Epithelial gap score
Epithelial gaps were defined as regions along the villi perimeter which exhibit breaks in the epithelial lining. Epithelial gap length of each individual epithelial gap was defined as the length from one end to the other end of the epithelial break, measured in pixels using Image J (Figure 1A). When more than one epithelial gap was present on an image, the lengths of all the epithelial gaps were added to give the epithelial gap total length. This measurement only captured epithelial gaps seen side-on. Tissue total perimeter was defined as the sum of the perimeter of all the tissue in an image, measured in pixels using Image J. Epithelial gap score was obtained by dividing the epithelial gap total length by the tissue total perimeter and multiplying this by a factor of 100.

Cell shedding score
Cell shedding was quantified by counting the shed cells in the intestinal lumen. Analysis of a representative image is shown in Figure 1B. The image is first divided into 4 quadrants. The shed cells in each quadrant of the image were scored as follows: zero point for no shed cell; one point for mild cell shedding (shed cells occupying less than 25% of lumen in the quadrant); and two points for severe cell shedding (shed cells occupying more than 25% of lumen in the quadrant). For each image, the minimum cell shedding score was 0, and maximum cell shedding score was 8 (when all 4 quadrants were scored 2 points each). For example, in Figure 1B, the left upper quadrant was scored as 2 points, because shed cells occupied more than 25% of the lumen in this quadrant. The other three quadrants were scored as 1 point each, as shed cells occupied less than 25% of the lumen in each of these quadrants. Therefore, the cell shedding score was 5 (2+1+1+1) for this image after totalling the scores for all four quadrants.

Luminal fluorescein score
Luminal fluorescein signal was compared with fluorescein signal from epithelial cells, and was scored as: 0 for predominantly black (more than 50% of lumen) in the absence of any region which appeared white; 1 for focally black (50% of lumen or less) in the absence of any region which appeared white; 2 for “darker than cells” representing lumen which appeared grey but is darker than that of the cells ; 3 for “same intensity as cells”; 4 for “brighter than cells” representing lumen which appeared grey but is brighter than that of the cells; 5 for “focally white” (50% of lumen or less); 6 for “predominantly white” (more than 50% of lumen). (Figure 1A)

Watson score
The endomicroscopic changes were simplified using the Watson score (Figure 3)
: I (normal) - Physiological cell shedding confined to single cells per shedding site and no local barrier dysfunction; II (functional defect) - Cell shedding confined to single cells per shedding site, fluorescein signal visible in the intestinal lumen or fluorescein plumes out of the epithelium into the lumen, intensity same or brighter than epithelium; III (structural defect) -- Micro erosions in any field (micro erosion is present when the lamina propria is exposed to the lumen with multiple cells being shed per site), fluorescein visible signal visible in the intestinal lumen or fluorescein plumes out of the epithelium into the lumen, intensity same or brighter than epithelium.[] 

Statistical Analysis
Data was analyzed with SPSS Statistics 17.0 (SPSS Inc., Chicago, IL, USA). Descriptive statistics for numerical data was presented as mean with standard deviation, median and range. Differences in categorical variables were evaluated using Fisher’s Exact test. Differences in continuous variables were evaluated using Mann Whitney U test for 2 groups comparison and Kruskal Wallis for 3 groups comparison. Pairwise comparisons was Bonferroni adjusted. Statistical significance was set at 2-sided p < 0.05. 

ETHICAL CONSIDERATIONS




15 patients with CD and 10 with UC were recruited.10 controls without colonic disease were also recruited. Their baseline characteristics are shown in Table 1. The mean CDAI score for CD patients was 253.3  115.9. The mean SCCAI score for UC patients was 6.0  2.9. Two patients with CD had undergone hemicolectomy (one right and one left hemicolectomy) and 2 had ileal resection. None of the patients with UC had undergone colectomy. None of the CD or UC patients had overt duodenal or gastric symptoms. None of the patients were taking aspirin or NSAIDs. None of the UC patients and only one CD patient was on anti-TNF treatment. The indication for oesophagogastroduodenoscopy for the 10 controls included gastroesophageal reflux disease in 5, dyspepsia in 3 and recurrent nausea or vomiting in 2. 

Macroscopic views of CD patients obtained at endoscopy showed normal gastric and duodenal mucosa in 10 patients, mild antral erythema in 4 patients, antral erythema with duodenal erosions in 1 patient. Eight patients with UC had macroscopically normal gastric and duodenal mucosa and 2 patients had antral erythema.  Macroscopically normal gastric and duodenal mucosa was seen in 6 control patients while the remaining 4 had antral erythema (Figure 2). All mucosal abnormalities (erythema) were targeted biopsied and microscopically examined (H&E staining). None of the biopsies showed specific changes associated with IBD. Mild, non-specific duodenitis was present in 7 CD patients, 2 control patients and in none of the UC patients (Figure 2). Among the 10 controls, histology in 8 subjects showed gastritis, of which 2 had histologically proven H. pylori gastritis. Coeliac disease or familial history of IBD was not present in any of the controls.

All confocal images were obtained from macroscopically normal mucosa. Nine representive images each from the first 8 subjects studied were selected for detailed analysis (3 each from antrum, D1 and D2). 15 images were analysed from each of the subsequent 27 subjects (3 each from antrum, D1, D2, D3 and D4), constituting a total of 477 confocal images. From each site, 3 representative images of good quality from 3 different z-stacks were used. (Figure 2)

CD patients and UC patients both had a significantly higher epithelial gap score, significantly more cell shedding, and a significantly higher luminal fluorescein score when compared to controls for the duodenum (Table 2). Gap, shedding and luminal fluorescein showed a trend to being higher in CD than UC but this did not reach statistical significance (Table 2).

We have previously devised a grading system for summarising changes seen on CLE called the Watson grading system.[] The Watson grades for CD and UC patients were significantly higher than for controls in the duodenum (Table 3), but not in the antrum (data not shown). 







There have been a number of clinical reports of patients with well-documented UC who subsequently presented with macroscopic upper gastrointestinal involvement. [10,11] A retrospective review of 5 paediatric IBD patients with gastroduodenal and pancolonic inflammation presumptively diagnosed with CD who were eventually diagnosed with UC after subtotal proctocolectomy suggests that UC may not be confined to the colon.  ADDIN EN.CITE [] However these cases were reported before CLE became available and so the endomicroscopic appearances of the duodenum in UC are unknown. [] 
The epithelial monolayer of the intestine maintains barrier function despite the high turnover of gut epithelial cells. This is achieved through a redistribution of proteins from the tight junction to around the shedding cell to plug the gap created by the extrusion process. ADDIN EN.CITE [,,] Barrier dysfunction is believed to play an important role in the pathogenesis of IBD.[,] Proinflammatory cytokines, such as TNF-α, are elevated in inflamed tissue of patients with IBD and this cytokine stimulates cell shedding. The tight junction redistribution mechanism for maintaining barrier function at sites of cellular extrusion starts to fail when shedding rates are high. ADDIN EN.CITE [,] Barrier dysfunction at the site of an epithelial gap may provide a site of entry for disease-causing bacteria  ADDIN EN.CITE [,]. In addition, the observed cell shedding in the duodenum is a possible mechanism responsible for the reduced iron absorption in subgroups of IBD patients with no duodenal involvement.
We have previously developed methods for scoring epithelial gaps, cell shedding and barrier function in fluorescein-based CLE which have been further refined in this study.[] We now normalise the number of gaps in a CLE against the amount of tissue in an image as measured by the perimeter of epithelium present. We found this method to be superior to other methods of normalisation. We also quantified the degree of fluorescein leakage by normalising it against tissue fluorescein fluorescence. 
Our study shows that both UC and CD patients have a structural epithelial defect in terms of increased shedding and gap formation when compared to healthy patients. A particularly noticeable feature of the gaps seen was they were often a diameter of more than one cell width indicating that more than one cell had been shed from a single site in the epithelium. We have called these gaps that have diameters of greater than one cell diameter “microerosions”. They are particularly associated with barrier loss. Our earlier study showed that shedding of a single cell from a site does not have prognostic significance in IBD whereas microerosions were predictive of relapse.[] We have previously devised a scoring system for CLE images combining cell shedding and barrier loss into a single number called the Watson score. This is also elevated in both UC and CD. We did not observe a consistent difference in gap formation, cell shedding or barrier loss between CD and UC. This may be because the inflammatory cytokine levels in duodenal mucosa are similar in both patient groups. Further studies are required to explore this possibility.
Patients with endoscopic active CD had numerically higher epithelial gap score, tissue fluorescein score, cell shedding score and luminal fluorescein score in the duodenum compared to those with endoscopic quiescent CD, but none were statistically significant except for D2 and D3 cell shedding score. This could be due to the small number of patients, and it is possible that in a future study that is properly powered to study the difference between active and quiescent CD, the epithelial gap score, tissue fluorescein score, cell shedding score and luminal fluorescein score in the duodenum may be statistically significantly more evident in active CD compared to quiescent CD.
A remarkable feature of our results is that the duodenal mucosa appeared normal in conventional white light endoscopy though we found evidence of a mild non-specific inflammation in biopsy samples as has been reported previously.  ADDIN EN.CITE [] One possibility is that these inflammatory changes were due to the bowel preparation for the colonoscopy. However we consider this to be unlikely as histological changes in the duodenum have been observed previously in studies where bowel preparation was not used.  ADDIN EN.CITE [] Furthermore the cell shedding and barrier loss in the duodenum is very unlikely to be due to the bowel preparation as these changes in the duodenum are identical to the cell shedding and barrier loss we have observed in the colon which have already shown predicts relapse of IBD. [8] 
We speculate that epithelial shedding, gap formation and localised barrier loss as measured by fluorescein-based CLE is a very sensitive indicator of circulating cytokine levels as we have shown already that TNF is a potent stimulant of cell shedding.[] Possible relation between anti-TNF treatments and cell shedding in IBD population cannot be determined in our study as there was only one CD patient on anti-TNF, but is of interest in future studies. Another intriguing implication of our observation of barrier loss in the duodenum is sites of entry of antigens, microbes or toxins that trigger colonic inflammation may not be restricted to the colon but may occur at sites in the upper intestine as has been previously suggested. [] Faecal calprotectin has been shown to correlate well with mucosal disease activity, but was not measured in our study, and was a limitation in our study.  
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Table 1. Baseline characteristics of subjects.
	CD (n=15)	UC (n=10)	Control (n=10)	p-value
Age (years)Mean (sd)MedianRange	40.0 (12.0)41.021 - 57	49.8(20.0)51.524 - 73	50.1 (12.6)53.028 – 68	0.149
Males n (%)	9 (60)	6 (60)	6 (60)	1.000
IBD duration  (months)Mean (sd)MedianRange	144.0 (127.7)93.00 - 382	148.2(175.2)76.012 – 544	NA	0.760
CDAI for CD SCCAI for UCMean (sd)MedianRange	253.3 (115.9)260.079 – 566	6.0 (2.9)5.03 – 11	NA	NA
White cell count (109/L)Mean (sdMedianRange	8.82 (3.61)8.74 - 18	8.18(3.17)8.34.8 – 13.9	NA	0.717
C-reactive protein (mg/L)Mean (sdMedianRange	25.4 (38.9)7.11.5 - 131	20.5(23.3)14.90.73 - 760	NA	0.687

Table 2. Confocal endomicroscopic parameters of CD patients, UC patients and controls. Epithelial gap score was obtained by dividing the epithelial gap total length by the tissue total perimeter and multiplying this by a factor of 100. Cell shedding score ranged from 0 to 8. Luminal fluorescein score ranged from 0 to 6. Kruskal Wallis test performed. P-values were bonferroni adjusted (inflated by 3)

	CD	UC	Controls	P value, CD vs controls	P value, UC vs controls	P value, CD vs UC
D1 gapsMean (sd)Medianrange 	2.19 (1.64)2.310.32 – 5.63	1.96 (1.78)1.790.0 – 5.31	(0.0)(0.0)(0.0)	0.002	0.014	1.0
D1 sheddingMean (SD)MedianRange 	2.18 (1.32)2.00.33 – 4.33	1.64 (1.02)1.690.33 – 4.0	0.47 (0.72)0.00.0 – 1.7	0.002	0.071	0.710
D1 luminal fluoresceinMean (sd)MedianRange 	3.42 (1.10)3.671.33 – 5.0	2.87 (1.07)2.851.67 – 4.33	0.80 (1.03)0.150.0 – 2.7	< 0.001	< 0.001	0.665
D2 gapsMean (sd)MedianRange	4.60 (6.66)2.63 0.33 – 27.1	3.08 (3.07)2.270.0 – 7.54	0.0 (0.0)0.0 (0.0)0.0 (0.0)	0.067	0.459	1.0
D2 sheddingMean (sd)MedianRange	2.51 (1.53)2.330.67 – 6.0	1.86 (0.91)2.00.0 – 2.67)	0.36 (0.54)0.00.0 – 1.3	< 0.001	0.02	0.557
D2 luminal fluoresceinMean (sd)MedianRange 	3.78 (1.45)4.00.67 – 5.67	3.23 (1.54)3.170.0 – 5.67	0.86 (1.17)0.00.0 – 3.0	< 0.001	0.002	1.0
D3 gapsMean (sd)MedianRange	4.96 (5.75)2.440.13 – 16.5	2.59 (3.08)1.310.0 – 7.94	0.0 (0.0)0.0 (0.0)0.0 (0.0)	0.031	0.548	0.634
D3 sheddingMean (sd)MedianRange 	2.77 (1.20)3.00.67 – 4.67	1.66 (1.37)1.00.33 – 4.0	0.44 ( 0.65)0.00.0 – 1.67	< 0.001	0.097	0.139
D3 luminal fluoresceinMean (sd)MedianRange 	3.93 (0.64)4.02.67 – 4.67	2.65 (1.44)2.51.0 – 4.67	1.07 (1.35)0.670.0 – 4.0	< 0.001	0.030	0.094
D4 gapsMean (sd)MedianRange	5.87 (4.84)3.741.44 – 15.3	2.01 (1.83)1.460.0 – 5.72	0.10 ( 0.31)0.00.0 – 0.94	0.002	0.671	0.100
D4 sheddingMean (sd)MedianRange 	2.50 (1.24)2.170.67 – 4.33	2.33 (1.31)2.170.33 – 4.0	0.56 (0.67)0.670.0 – 2.0	0.003	0.010	1.0
D4 luminal fluoresceinMean (sd)MedianRange 	4.00 (1.59)4.671.0 – 6.0	3.54 (0.93)4.01.33 – 4.0	1.29 (1.19)1.00.0 – 3.0	< 0.001	0.005	1.0

Table 3. Watson Grades in the duodenum of CD, UD and control patients. Watson grade. I (normal) -- Physiological cell shedding confined to single cells per shedding site and no local barrier dysfunction; II (barrier defect) -- Cell shedding confined to single cells per shedding site, fluorescein signal visible in the intestinal lumen or fluorescein plumes out of the epithelium into the lumen, intensity same or brighter than epithelium; III (erosions + barrier defect) -- Micro erosions in any field (micro erosion is present when the lamina propria is exposed to the lumen with multiple cells being shed per site), fluorescein visible signal visible in the intestinal lumen or fluorescein plumes out of the epithelium into the lumen, intensity same or brighter than epithelium. Fisher’s Exact test performed. P-values were bonferroni adjusted (inflated by 3)

Site	Watson score	CD (number of patients)	UC (number of patients)	Controls (number of patients)	P value CD vs controls (I vs II/III)	P value UC vs controls (I vs II/III)	P value CD vs UC
D1	I	0 (0.0)	0 (0.0)	8 (80.0)	<0.001	<0.001	1.0
	II	4 (26.7)	2 (20.0)	2 (20.0)			
	III	11 (73.3)	8 (80.0)	0 (0.0)			
D2	I	0 (0.0)	0 (0.0)	8 (80.0)	<0.001	<0.001	1.0
	II	2 (13.3)	2 (20.0)	2 (20.0)			
	III	13 (86.7)	8 (80.0)	0 (0.0)			
D3	I	0 (0.0)	0 (0.0)	8 (88.9)	<0.001	<0.001	0.549
	II	0 (0.0)	2 (25.0)	1 (11.1)			
	III	10 (100)	6 (75.0)	0 (0.0)			
D4	I	0 (0.0)	0 (0.0)	6 (66.7)	0.006	0.012	NA
	II	0 (0.0)	0 (0.0)	2 (22.2)			










Table 4. Confocal endomicroscopic parameters of patients with endoscopic quiescent CD and active CD. Mann Whitney U test performed.

	Quiescent CD(n = 5)	Active CD(n = 10)	P value (Quiescent vs active CD)	Controls
D1 gapsMean (sd)MedianRange	1.54 (1.20)1.020.32 – 2.93	2.51 (1.78)2.380.49 – 5.63	0.440	0.0 (0.0)0.0 (0.0)(0.0)
D1 sheddingMean (sd)MedianRange	1.93 (1.40)1.331.0 – 4.33	2.30 (1.33)2.670.33 – 4.0	0.594	0.47 (0.72)0.00.0 – 1.7
D1 luminal fluoresceinMean (sd)MedianRange	3.39 (0.98)3.332.0 – 4.33	3.43 (1.20)3.841.33 – 5.0	0.953	0.80 (1.03)0.150.0 – 2.7
D2 gapsMean (sd)MedianRange	1.85 (1.70)1.430.33 – 4.45	5.98 (7.83)3.450.58 – 27.1	0.129	0.0 (0.0)0.0 (0.0)0.0 (0.0)
D2 sheddingMean (sd)MedianRange	1.33 (0.78)1.00.67 – 2.67	3.10 (1.49)2.670.67 – 6.0	0.040	0.36 (0.54)0.00.0 – 1.3
D2 luminal fluoresceinMean (sd)medianRange	3.33 (1.84)4.01.0 – 5.67	4.00 (1.27)4.170.67 – 5.33)	0.513	0.86 (1.17)0.00.0 – 3.0
D3 gapsMean (sd)medianRange	2.92 (2.73)2.440.13 – 6.69	6.33 (7.03)2.540.7 – 16.5	0.762	0.0 (0.0)0.0 (0.0)0.0 (0.0)
D3 sheddingMean (sd)medianRange	2.08 (1.22)2.00.67 – 3.67	3.22 (1.02)3.01.67 – 4.67	0.257	0.44 ( 0.65)0.00.0 – 1.67
D3 luminal fluoresceinMean (sd)medianRange	3.58 (0.92)3.52.67 – 4.67	4.17 (0.28)4.04.0 – 4.67	0.352	1.07 (1.35)0.670.0 – 4.0
D4 epithelial gap scoreMean (sd)medianRange	3.88 (2.52)3.411.44 – 7.27	7.20 (5.75)5.691.84 – 15.3	0.476	0.10 ( 0.31)0.00.0 – 0.94
D4 sheddingMean (sd)medianRange 	2.41 (0.87)2.171.67 – 3.67	2.55 (1.52)2.340.67 – 4.33	0.914	0.56 (0.67)0.670.0 – 2.0
D4 luminal fluoresceinMean (sd)medianRange 	4.00 (1.33)4.672.0 – 4.67	4.00 (1.87)4.51.0 – 6.0	0.762	1.29 (1.19)1.00.0 – 3.0

Figure Legends
Figure 1A. The measurement of the epithelial gap score. The red line marks the length from one end to the other end of the epithelial break. The marked area (Yellow Arrow) also represents a fluorescein plume out of the epithelium into the lumen, which appears as a focally white region, giving this image a luminal fluorescein score of 5 (“focally white”).
Figure 1B. Quantification of cell shedding score. See methods for details.
Figure 2. Endoscopy, confocal laser endoscopy and histology of control (A-C), UC (D-F) and CD (G-I) patients. Standard endoscopic views are shown if panels A, D & G, confocal laser endoscopic views in panels B, E & H and histological sections stained with Haematoxylin and Eosin in panels C, F and I.

Figure 3. The Watson grading system. A. Grade 1, B. Grade II, C & D, Grade III (See text for details).



